Literature DB >> 8997761

The future of smoking cessation therapy in the United States.

J R Hughes1.   

Abstract

Six trends that are likely to influence the future content, format, delivery and reach of smoking cessation therapy in the United States are discussed: (1) changing characteristics of smokers (e.g. more likely to be poor, have psychiatric co-morbidity and be more nicotine dependent), (2) health care reform demands for cost-effectiveness, (3) development of guidelines/algorithms that recommend stepped-care approaches, (4) continued emphasis on smoking as a form of drug dependence requiring intensive pharmacological and behavior therapy for some smokers, (5) interest in harm-reduction strategies for smokers unable or unwilling to quit (and 6) smoking cessation therapies become reimbursable on par with other drug dependencies.

Entities:  

Mesh:

Year:  1996        PMID: 8997761     DOI: 10.1046/j.1360-0443.1996.911217974.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  22 in total

1.  Individualized stepped care of chronic illness.

Authors:  M Von Korff; B Tiemens
Journal:  West J Med       Date:  2000-02

2.  Characterizing and identifying "hard-core" smokers: implications for further reducing smoking prevalence.

Authors:  S Emery; E A Gilpin; C Ake; A J Farkas; J P Pierce
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

3.  Social support mediates the association of health literacy and depression among racially/ethnically diverse smokers with low socioeconomic status.

Authors:  Diana W Stewart; Lorraine R Reitzel; Virmarie Correa-Fernández; Miguel Ángel Cano; Claire E Adams; Yumei Cao; Yisheng Li; Andrew J Waters; David W Wetter; Jennifer Irvin Vidrine
Journal:  J Behav Med       Date:  2014-04-08

4.  Enhancing dissemination of smoking cessation quitlines through T2 translational research: a unique partnership to address disparities in the delivery of effective cessation treatment.

Authors:  Jennifer Irvin Vidrine; Vance Rabius; Margo Hilliard Alford; Yisheng Li; David W Wetter
Journal:  J Public Health Manag Pract       Date:  2010 Jul-Aug

5.  Transdisciplinary Tobacco Use Research Centers: research achievements and future implications.

Authors:  Timothy B Baker; K Michael Cummings; Dorothy K Hatsukami; C Anderson Johnson; Caryn Lerman; Raymond Niaura; Stephanie S O'Malley
Journal:  Nicotine Tob Res       Date:  2009-07-24       Impact factor: 4.244

6.  Distress tolerance treatment for early-lapse smokers: rationale, program description, and preliminary findings.

Authors:  Richard A Brown; Kathleen M Palm; David R Strong; Carl W Lejuez; Christopher W Kahler; Michael J Zvolensky; Steven C Hayes; Kelly G Wilson; Elizabeth V Gifford
Journal:  Behav Modif       Date:  2008-05

7.  Nicotine modulates alcohol-seeking and relapse by alcohol-preferring (P) rats in a time-dependent manner.

Authors:  Sheketha R Hauser; Bruk Getachew; Scott M Oster; Ronnie Dhaher; Zheng-Ming Ding; Richard L Bell; William J McBride; Zachary A Rodd
Journal:  Alcohol Clin Exp Res       Date:  2011-06-20       Impact factor: 3.455

8.  Smoking behavior and motivation to quit among chronic pain patients initiating multidisciplinary pain treatment: a prospective study.

Authors:  Marina Unrod; Ronald J Gironda; Michael E Clark; Kristi E White; Vani N Simmons; Steven K Sutton; Thomas H Brandon
Journal:  Pain Med       Date:  2014-02-15       Impact factor: 3.750

9.  Associations of mindfulness with nicotine dependence, withdrawal, and agency.

Authors:  Jennifer Irvin Vidrine; Michael S Businelle; Paul Cinciripini; Yisheng Li; Marianne T Marcus; Andrew J Waters; Lorraine R Reitzel; David W Wetter
Journal:  Subst Abus       Date:  2009 Oct-Dec       Impact factor: 3.716

10.  A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers.

Authors:  Andrea H Weinberger; Erin L Reutenauer; Peter I Jatlow; Stephanie S O'Malley; Marc N Potenza; Tony P George
Journal:  Drug Alcohol Depend       Date:  2009-11-24       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.